Skip to main content

Table 1

From: Therapeutic drug monitoring (TDM) of atazanavir in pregnancy

  T1 (n=10) T2 (n=17) T3 (n=27) PP (n=21) P value
[ATV], µg/mL 1.03 (0.49-2.53) 0.75 (0.59-1.45) 0.66 (0.63-1.03) 1.17 (1.09-1.81) 0.06
CV, % 108 84 59 55 -
Time of sampling, h 14.6 (12.5-17.5) 18.0 (16-21.8) 19.0 (17.6-21.9) 19.1 (17.4-22.3) 0.102